We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation.
- Authors
Metro, Giulio; Chiari, R; Mare, M; Giannarelli, D; Tofanetti, F R; Minotti, V; Ferraldeschi, M; Giuffrida, D; Marcomigni, L; Bennati, C; Fischer, M J; Meacci, M; Bellavita, R; Pistola, L; Ludovini, V; Crinò, L
- Abstract
In the present study, the combination of carboplatin (CBDCA) plus pemetrexed (PMX) for the treatment of patients with platinum-pretreated, pemetrexed-naïve, advanced non-small cell lung cancer (NSCLC) was investigated. Also, single nucleotide polymorphisms (SNPs) at the XRCC3, XPD, ERCC1, GARFT, DHFR, and TS genes were investigated.
- Publication
Cancer chemotherapy and pharmacology, 2011, Vol 68, Issue 6, p1405
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-011-1632-x